Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 9 | 2 | 1 | 1 | 13 |
Prostatic neoplasms | D011471 | — | C61 | — | 3 | — | 3 | — | 6 |
Neoplasms | D009369 | — | C80 | 2 | 1 | — | 1 | — | 4 |
Autologous transplantation | D014182 | — | — | — | — | — | 1 | 2 | 3 |
Neutropenia | D009503 | — | D70 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | — | 9 | 1 | — | 3 | 13 |
Lymphoma | D008223 | — | C85.9 | 1 | 4 | 1 | — | 2 | 7 |
Crohn disease | D003424 | EFO_0000384 | K50 | 1 | 4 | 3 | — | — | 7 |
Melanoma | D008545 | — | — | — | 1 | 1 | — | — | 2 |
Aplastic anemia | D000741 | — | D61.9 | — | 1 | 1 | — | — | 2 |
Anemia | D000740 | EFO_0004272 | D64.9 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 3 | 5 | — | — | — | 7 |
Leukemia | D007938 | — | C95 | 3 | 3 | — | — | — | 5 |
Myeloid leukemia | D007951 | — | C92 | 2 | 2 | — | — | — | 4 |
Myelodysplastic syndromes | D009190 | — | D46 | 1 | 3 | — | — | — | 3 |
Hodgkin disease | D006689 | — | C81 | — | 3 | — | — | — | 3 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 2 | — | — | — | 2 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | 2 | — | — | — | 2 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 2 | — | — | — | 2 |
Hematopoietic stem cell transplantation | D018380 | — | — | — | 1 | — | — | 1 | 2 |
Plasma cell neoplasms | D054219 | — | — | — | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hematologic neoplasms | D019337 | — | — | 1 | — | — | — | — | 1 |
Fallopian tube neoplasms | D005185 | — | — | 1 | — | — | — | — | 1 |
Ovarian epithelial carcinoma | D000077216 | — | — | 1 | — | — | — | — | 1 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoproliferative disorders | D008232 | Orphanet_2442 | D47.9 | — | — | — | — | 1 | 1 |
Paraproteinemias | D010265 | — | D47.2 | — | — | — | — | 1 | 1 |
Drug common name | Molgramostim |
INN | molgramostim |
Description | Molgramostim is a recombinant granulocyte macrophage colony-stimulating factor which functions as an immunostimulator.
|
Classification | Protein |
Drug class | colony-stimulating factors: granulocyte macrophage colony-stimulating factors (GM-CSF); colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109134 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | B321AL142J (ChemIDplus, GSRS) |